2639 – The Effectiveness of Agomelatine (Valdoxan) in the Treatment of Atypical Depression

@article{Avedisova20132639T,
  title={2639 – The Effectiveness of Agomelatine (Valdoxan) in the Treatment of Atypical Depression},
  author={A S Avedisova and M P Marachev},
  journal={European Psychiatry},
  year={2013},
  volume={28},
  pages={1 - 1}
}
Introduction: Treatment of atypical depression (AD) modern antidepressants poorly understood, whereas the study of AD in the context of chronobiological disorders necessitates selection pathogenetically substantiated therapy. Objectives: To determine the effectiveness of agomelatine in the treatment of AD. Aims: To compare the efficacy of agomelatine in patients with AD and melancholic depression (MD), the impact of the drug on the separate atypical symptoms, and the effect on AD in the first… Expand
Spin-orbit Torque and Spin Hall Effect-based Cellular Level Therapeutic Neuromodulators: Modulating Neuron Activities through Spintronic Nanodevices
Artificial modulation of a neuronal subset through ion channels activation can initiate firing patterns of an entire neural circuit in vivo. As nanovalves in the cell membrane, voltage-gated ionExpand